Cleveland Clinic's Top 10 Medical Innovations For 2009
This article was originally published in The Gray Sheet
Executive Summary
1. Use of circulating tumor cell technology: A blood test assessing chemotherapy progress by measuring for cancer cells that have broken away from an existing tumor and entered the bloodstream.
You may also be interested in...
Synapse Biomedical Debuts Diaphragm Pacer, HDE-Cleared To Aid Breathing
Synapse Biomedical will pursue expanded approval of its diaphragm pacing system to facilitate breathing in patients with Lou Gehrig's disease after gaining a humanitarian device exemption June 17 for use by ventilator-dependent spinal cord injury patients, according to the company
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.